← Leaderboards
Dale E. Bredesen
University Of California San Diego
$12,603,293
Attributed
$12,603,293
Total exposure
15
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–14$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$19,621,844 · 18
By mechanism
R01$7,627,447 · 4
C06$5,800,000 · 6
P30$2,273,703 · 2
P50$1,905,910 · 2
T32$799,502 · 1
G20$675,119 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Kyonsoo Hong$3,560,953
- Mu-Ming Poo$12,066,674
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCysteine EndopeptidasesEnzyme ActivityPhenotypeNeural DegenerationGene ExpressionNeurogeneticsBaseAlzheimer&AposS DiseaseCell DeathTissue /Cell CultureMutantYeast Two Hybrid SystemProductionSignal TransductionMediatingMolecular PathologyMembraneNetrin-1NeuronsAmyotrophic Lateral SclerosisAgingBinding (Molecular Function)
Grant awards (47)
UCLA Alzheimer's Disease Research Center$1,896,670
P50 · FY2014 · AG · contact PI
APP signaling network$229,163
R21 · FY2013 · AG · contact PI
Novel Prionic Mechanism Underlying Alzheimer?s Disease$369,217
R01 · FY2012 · AG · contact PI
APP signaling network$291,000
R21 · FY2012 · AG · contact PI
Novel Prionic Mechanism Underlying Alzheimer?s Disease$369,217
R01 · FY2011 · AG · contact PI
Novel Prionic Mechanism Underlying Alzheimer?s Disease$384,120
R01 · FY2010 · AG · contact PI
Novel Prionic Mechanism Underlying Alzheimer?s Disease$388,000
R01 · FY2009 · AG · contact PI
Basic Mechanisms in Aging and Age Related Disease$712,555
P30 · FY2007 · AG · contact PI
Development and Improvement of an Animal Resource Core$675,119
G20 · FY2007 · RR · contact PI
Novel apoptotic pathway activated by misfolded proteins$436,875
R01 · FY2007 · NS · contact PI
Mechanism of apoptosis induction by the receptor DCC$322,909
R01 · FY2007 · NS · contact PI
Basic Mechanisms in Aging and Age Related Disease$75,000
P30 · FY2007 · AG · contact PI
Basic Mechanisms in Aging and Age Related Disease$714,327
P30 · FY2006 · AG · contact PI
Novel apoptotic pathway activated by misfolded proteins$449,923
R01 · FY2006 · NS · contact PI
Mechanism of apoptosis induction by the receptor DCC$332,553
R01 · FY2006 · NS · contact PI
Training in Age-Related Disease and Aging Research$210,962
T32 · FY2006 · AG · contact PI
Basic Mechanisms in Aging and Age Related Disease$719,999
P30 · FY2005 · AG
Novel apoptotic pathway activated by misfolded proteins$460,750
R01 · FY2005 · NS
Mechanism of apoptosis induction by the receptor DCC$340,556
R01 · FY2005 · NS
Mechanism of inhibition of neurodegeneration and aging$339,500
R01 · FY2005 · AG
Training in Age-Related Disease and Aging Research$207,722
T32 · FY2005 · AG
ADMINISTRATIVE CORE$51,822
P30 · FY2005 · AG
Buck Institute--Pharmacology of Lifespan Extension$20,000
R13 · FY2005 · AG
Center for Integrative Studies of Aging$2,900,000
C06 · FY2004 · RR
CTR FOR INTEGRATIVE STUDIES OF AGING: AGED RELATED DIS: NEURODEGENERATION, PD, A$1,450,000
C06 · FY2004 · RR
CTR FOR INTEGRATIVE STUDIES OF AGING: AGING RES, LONGIVITY$580,000
C06 · FY2004 · RR
Novel apoptotic pathway activated by misfolded proteins$460,750
R01 · FY2004 · NS
Mechanism of apoptosis induction by the receptor DCC$340,556
R01 · FY2004 · NS
Mechanism of inhibition of neurodegeneration and aging$339,500
R01 · FY2004 · AG
CTR FOR INTEGRATIVE STUDIES OF AGING: BREAST &PROSTATE CANCER$290,000
C06 · FY2004 · RR
CTR FOR INTEGRATIVE STUDIES OF AGING: ADDITION, OPIATE PEPTIDES$290,000
C06 · FY2004 · RR
CTR FOR INTEGRATIVE STUDIES OF AGING: GENETICS, GENOMICS &PROTEOMICS$290,000
C06 · FY2004 · RR
Training in Age-Related Disease and Aging Research$194,269
T32 · FY2004 · AG
Novel apoptotic pathway activated by misfolded proteins$460,750
R01 · FY2003 · NS
Mechanism of apoptosis induction by the receptor DCC$362,881
R01 · FY2003 · NS
Mechanism of inhibition of neurodegeneration and aging$339,500
R01 · FY2003 · AG
Training in Age-Related Disease and Aging Research$100,357
T32 · FY2003 · AG
Mechanism of inhibition of neurodegeneration and aging$339,500
R01 · FY2002 · AG
Training in Age-Related Disease and Aging Research$86,192
T32 · FY2002 · AG
ROLE OF CASPASE CLEAVAGE IN NEURODEGENERATIVE DISEASES$0
P50 · FY2002 · AG
Mechanism of inhibition of neurodegeneration and aging$339,500
R01 · FY2001 · AG
Mechanism of inhibition of neurodegeneration and aging$152,507
R01 · FY2001 · AG
ROLE OF CASPASE CLEAVAGE IN NEURODEGENERATIVE DISEASES$0
P50 · FY2001 · AG
MONOCLONAL ANTIBODY THAT INDUCES NEURONAL APOPTOSIS$298,383
R01 · FY2000 · NS
ROLE OF CASPASE CLEAVAGE IN NEURODEGENERATIVE DISEASES$9,240
P50 · FY2000 · AG
ROLE OF CASPASE CLEAVAGE IN NEURODEGENERATIVE DISEASES$0
P50 · FY2000 · AG
ROLE OF CASPASE CLEAVAGE IN NEURODEGENERATIVE DISEASES$0
P50 · FY2000 · AG